Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$452M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$359M |
| 3 |
Accenture
ACN
|
+$329M |
| 4 |
Becton Dickinson
BDX
|
+$318M |
| 5 |
Coca-Cola
KO
|
+$269M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$517M |
| 2 |
Chevron
CVX
|
+$454M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$355M |
| 5 |
Dollar Tree
DLTR
|
+$348M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.79% |
| 2 | Financials | 11.74% |
| 3 | Healthcare | 10.79% |
| 4 | Consumer Discretionary | 8.84% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Agnico Eagle Mines
AEM
$93.8B
| $920K | ﹤0.01% |
15,204
+2,508
| +20% | +$167K |
|
3202
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.28B
| $919K | ﹤0.01% |
17,943
+478
| +3% | +$24.2K |
|
3203
KB Financial Group
KB
$41.3B
| $912K | ﹤0.01% |
18,504
+746
| +4% | +$37.2K |
|
3204
BlackRock Enhanced International Dividend Trust
BGY
$533M
| $911K | ﹤0.01% |
138,731
-6,964
| -5% | -$44.4K |
|
3205
Verra Mobility
VRRM
$715M
| $911K | ﹤0.01% |
59,270
+3,495
| +6% | +$50.7K |
|
3206
Invesco S&P 500 Value with Momentum ETF
SPVM
$132M
| $910K | ﹤0.01% |
18,677
+2,873
| +18% | +$140K |
|
3207
Team
TISI
$102M
| $898K | ﹤0.01% |
13,396
-169
| -1% | -$15.4K |
|
|
RFI
3208
Cohen & Steers Total Return Realty Fund
RFI
$304M
| $894K | ﹤0.01% |
55,062
-71,581
| -57% | -$1.11M |
|
|
CTRA
3209
CALL
DELISTED
Coterra Energy
CTRA
| $883K | ﹤0.01% |
+50,600
| New | +$861K |
|
|
ICPT
3210
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $881K | ﹤0.01% |
44,118
+20,709
| +88% | +$411K |
|
|
SRNE
3211
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $881K | ﹤0.01% |
93,461
+11,895
| +15% | +$94.7K |
|
3212
iShares MSCI Malaysia ETF
EWM
$333M
| $877K | ﹤0.01% |
34,310
+10,007
| +41% | +$272K |
|
3213
Hercules Capital
HTGC
$3.11B
| $877K | ﹤0.01% |
51,397
+746
| +1% | +$12.8K |
|
3214
iShares Global Consumer Staples ETF
KXI
$1.06B
| $876K | ﹤0.01% |
15,255
+4,894
| +47% | +$298K |
|
3215
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.35B
| $876K | ﹤0.01% |
9,897
+6,180
| +166% | +$554K |
|
3216
Invesco DB US Dollar Index Bullish Fund
UUP
$415M
| $876K | ﹤0.01% |
35,267
-31,470
| -47% | -$770K |
|
3217
Fresenius Medical Care
FMS
$12.6B
| $873K | ﹤0.01% |
21,007
+3,182
| +18% | +$127K |
|
|
KW
3218
DELISTED
Kennedy-Wilson Holdings
KW
| $873K | ﹤0.01% |
43,907
-80,981
| -65% | -$1.64M |
|
3219
Rithm Capital
RITM
$5.71B
| $868K | ﹤0.01% |
81,900
+765
| +0.9% | +$8.13K |
|
3220
Seer Inc
SEER
$118M
| $865K | ﹤0.01% |
26,392
+5,676
| +27% | +$224K |
|
3221
Axogen
AXGN
$2.64B
| $864K | ﹤0.01% |
39,974
-38,937
| -49% | -$787K |
|
3222
Regional Management Corp
RM
$293M
| $862K | ﹤0.01% |
+18,530
| New | +$802K |
|
|
PDM
3223
Piedmont Realty Trust
PDM
$1.18B
| $855K | ﹤0.01% |
46,265
-15,704
| -25% | -$292K |
|
3224
Invesco Bond Fund
VBF
$168M
| $854K | ﹤0.01% |
41,130
+6,648
| +19% | +$132K |
|
3225
NatWest
NWG
$76.7B
| $853K | ﹤0.01% |
140,343
+6,269
| +5% | +$37.9K |
|
Similar funds
Ameriprise's Q2 2021 Portfolio in Review
As of Q2 2021, Ameriprise held 4,059 positions worth $323B, up 7.5% from $301B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Ameriprise's Q2 2021 filing shows 217 new, 1,726 increased, 1,816 reduced and 179 closed positions. Its largest new stake was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M. The largest sale was UnitedHealth, an estimated $517M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q2 2021 buy was NiSource Inc. Series A Corporate Units: 830,300 shares worth $85.5M.
- Ameriprise added most to ExxonMobil in Q2 2021, an estimated $452M increase.
- Ameriprise's biggest Q2 2021 reduction was UnitedHealth, cutting an estimated $517M.
- Ameriprise fully exited INPHI CORPORATION in Q2 2021, selling an estimated $139M.
- Ameriprise's ten largest holdings make up 15% of its $323B portfolio in Q2 2021.
- Ameriprise opened 217 new positions and closed 179 in Q2 2021.
- Ameriprise's portfolio value rose 7.5% quarter-over-quarter to $323B.
Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.